Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFD-01 HPA Axis Suppression in Adolescents with Plaque Psoriasis
NCT02527421Phase 3Terminated
- Sponsor
- Primus Pharmaceuticals
- Start
- Aug 2015
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of betamethasone dipropionate spray 0.05% in plaque psoriasis, sponsored by Primus Pharmaceuticals. Started Aug 2015; status: terminated.
02
Drugs
betamethasone dipropionate spray 0.05%
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02527421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02527421.